Myringitis (Middle Ear, Tympanic Membrane, Inflammation) Questions & Answers

1. Kasinathan S, Kondamudi NP. Bullous Myringitis. StatPearls. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].

2. Elzir L, Saliba I. Bullous hemorrhagic myringitis. Otolaryngol Head Neck Surg. 2013 Feb. 148 (2):347-8. [QxMD MEDLINE Link].

3. Crapko M, Kerschner JE, Syring M, Johnston N. Role of extra-esophageal reflux in chronic otitis media with effusion. Laryngoscope. 2007 Aug. 117(8):1419-23. [QxMD MEDLINE Link].

4. Van Dyke MK, Pircon JY, Cohen R, et al. Etiology of Acute Otitis Media in Children Less Than 5 Years of Age: A Pooled Analysis of 10 Similarly Designed Observational Studies. Pediatr Infect Dis J. 2017 Mar. 36 (3):274-81. [QxMD MEDLINE Link]. [Full Text].

5. Crowson MG, Callahan K, Saunders JE. Review of otorrhea microbiology: is there a pathogenic role of corynebacter?. Otol Neurotol. 2015 Feb. 36(2):244-9. [QxMD MEDLINE Link].

6. Rezes S, Késmárki K, Sipka S, Sziklai I. Characterization of otitis media with effusion based on the ratio of albumin and immunoglobulin G concentrations in the effusion. Otol Neurotol. 2007 Aug. 28(5):663-7. [QxMD MEDLINE Link].

7. Barclay L. Postop Tympanostomy Tube Obstruction Common. Medscape Medical News. Jul 11 2014. [Full Text].

8. Conrad DE, Levi JR, Theroux ZA, et al. Risk Factors Associated With Postoperative Tympanostomy Tube Obstruction. JAMA Otolaryngol Head Neck Surg. 2014 Jul 10. [QxMD MEDLINE Link].

9. Chung J, Lee DY, Kim YH. Management of myringitis: Current concepts and review. Laryngoscope. 2018 Sep. 128 (9):2157-62. [QxMD MEDLINE Link].

10. Phillips JS, Yung MW, Nunney I. Myringoplasty outcomes in the UK. J Laryngol Otol. 2015 Sep. 129 (9):860-4. [QxMD MEDLINE Link].

11. Berglund M, Olaison S, Bonnard A, et al. Hearing outcome after myringoplasty in Sweden: A nationwide registry-based cohort study. Clin Otolaryngol. 2020 May. 45 (3):357-63. [QxMD MEDLINE Link].

12. Deschuytere L, Van Hoecke H, De Leenheer E, Loose D, Dhooge I. Long-term anatomic and functional outcome of pediatric myringoplasty in primary and revision cases. Int J Pediatr Otorhinolaryngol. 2022 Nov. 162:111313. [QxMD MEDLINE Link].

John Schweinfurth, MD Professor, Department of Otolaryngology, University of Mississippi Medical Center

John Schweinfurth, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Laryngological Association, Triological Society, American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association

Disclosure: Nothing to disclose.

Yuri P Uliyanov, MD, PhD Director, Department of Ear, Nose, and Throat, Agami Medical Center

Yuri P Uliyanov, MD, PhD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Gerard J Gianoli, MD Clinical Associate Professor, Departments of Otolaryngology-Head and Neck Surgery and Pediatrics, Tulane University School of Medicine; President, The Ear and Balance Institute; Board of Directors, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, Triological Society

Disclosure: Nothing to disclose.

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan; Ryte; Neosoma; MI10<br/>Received income in an amount equal to or greater than $250 from: Neosoma; Cyberionix (CYBX)<br/>Received ownership interest from Cerescan for consulting for: Neosoma, MI10.

Michael E Hoffer, MD Director, Spatial Orientation Center, Department of Otolaryngology, Naval Medical Center of San Diego

Michael E Hoffer, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: Received royalty from American biloogical group for other.

• Print this section
• Print the entire contents of
• Print the entire contents of article